MedTech News
Clearmind Biomedical wins FDA clearance for Neuroblade minimally invasive neuroendoscopy tech
Clearmind Biomedical announced today that it received FDA 510(k) clearance for its Neuroblade neuroendoscopy system.
OBVIUS Robotics™ Receives U.S. FDA Breakthrough Device Designation for CERTA™ Access System for Central Venous Catheterization
SUNRISE, Fla., Aug. 26, 2024 /PRNewswire/ — Obvius Robotics, a medical device company developing an innovative technology platform for democratizing vascular access, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its CERTA Access System for central venous catheterization (CVC).
Insulet expands Omnipod 5 pump to people with Type 2 diabetes
The FDA clearance marks the first automated insulin delivery system for people with Type 2 diabetes.
Olympus Launches New POWERSEAL™ Sealer/Divider 5mm Devices, Extends Advanced Bipolar Surgical Energy Portfolio
WESTBOROUGH, Mass., Aug. 26, 2024 /PRNewswire/ — Olympus Corporation, a global medical technology company committed to making people’s lives healthier, safer, and more fulfilling, announced today the launch of two new jaw designs in the POWERSEAL™ Sealer/Divider family of advanced bipolar surgical energy products: the POWERSEAL Straight Jaw, Double-action (SJDA) and the POWERSEAL Curved Jaw, Single-action (CJSA). The first POWERSEAL device, launched in 2021, is the POWERSEAL Curved Jaw, Double-action (CJDA), which has established a strong foothold for Olympus in the advanced bipolar surgical energy market.
Spartan Medical Launches the Melzi Sharps Finder to Help Hospitals Avoid Retained Surgical Sharps Miscounts
RENO, Nev. and ROCKVILLE, Md., Aug. 23, 2024 /PRNewswire/ — Melzi Surgical, a medical device company focused on providing innovative technology to locate lost surgical sharps and Spartan Medical Inc., a veteran-owned medical solutions company, have launched a campaign to raise awareness around the impacts of Retained Surgical Items (RSIs) and near-misses to provide a unique offering to reduce RSIs and potential consequences.
Resivant Medical Receives FDA Clearance for Two Novel High-Viscosity Tissue Adhesive Products Cutiva™ Topical Skin Adhesive and Cutiva™ PLUS Skin Closure System
AKRON, Ohio, Aug. 23, 2024 /PRNewswire/ — Resivant Medical announced today it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its first two products, Cutiva™ Topical Skin Adhesive, and Cutiva PLUS™ Skin Closure System, which combines an adhesive mesh patch with high-viscosity Cutiva™ liquid adhesive. This achievement represents a significant advancement in medical tissue adhesive and wound closure technology and marks the first major adhesive advancement in over 25 years.
Simple blood test for Alzheimer’s disease could change how the disease is detected and diagnosed
A paper published in Alzheimer’s Research & Therapy outlines a study undertaken by the Institute of Memory & Cognition at Tallaght University Hospital (TUH) which could change the way Alzheimer’s disease is detected.
SurGenTec wins FDA nod for bone marrow aspirate kit
SurGenTec announced today that it received FDA 510(k) clearance for its proprietary B-MAN bone marrow aspirate kit.